In addition, mRNAs for two of the three enzymes that also utilize Cer for biosynthesis of other sphingolipids (sphingomyelin synthase 1, SMS1, and ceramide kinase, CERK) and the Cer transport protein CERT appear to be lower for the carcinoma cells versus normal stromal tissue. This evidence concerns the gene SGMS1 and carcinoma.